微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 16.56% | -54.19% | -26.92% | 122/140 | 52.37% | 健帆生物 | 78.46% | 行业排名> |
| 2025-12-31 | 22.66% | 14.03% | 0.92% | 120/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 22.45% | 19.54% | 1.63% | 119/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 22.09% | 28.56% | -38.88% | 120/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 36.15% | 43.9% | 81.92% | 99/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 19.87% | -22.94% | 5.79% | 121/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 18.78% | -29.75% | 9.3% | 118/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 17.18% | -37.18% | -31.59% | 123/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 25.12% | -17.31% | -2.58% | 112/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 25.79% | -11.83% | -3.56% | 117/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 26.74% | 2% | -2.25% | 112/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 27.35% | 5.7% | -9.96% | 113/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 30.38% | 2% | 3.88% | 106/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 29.24% | 6.73% | 6.73% | 114/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2021-12-31 | 27.4% | -11.33% | 5.88% | 117/140 | 57.98% | 三友医疗 | 90.18% | 行业排名> |
| 2021-06-30 | 25.88% | 2% | -16.26% | 110/140 | 59.05% | 三友医疗 | 90.14% | 行业排名> |
| 2020-12-31 | 30.9% | 9.05% | 9.05% | 119/140 | 60.12% | 三友医疗 | 90.29% | 行业排名> |
| 2019-12-31 | 28.34% | -2.08% | -2.08% | 108/140 | 56.96% | 三友医疗 | 90.73% | 行业排名> |
| 2018-12-31 | 28.94% | -17.92% | -17.92% | 103/140 | 56.22% | 三友医疗 | 90.5% | 行业排名> |
| 2016-12-31 | 35.26% | 2% | 2% | 66/140 | 57.35% | 三友医疗 | 90.29% | 行业排名> |